Trial Site Detail

 

Drug:
Imatinib + BYL719
Trial:
A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Robert Roessle Comprehensive Cancer Center - Charite Campus Buch

Lindenberger Weg 80     
Berlin , D-13125
Germany

 

Principal Investigator:
Peter Reichardt, MD
Contact:
49-304-5055-3893 reichardt@rrk-berlin.de
Activation Status of this Site:
Closed
Notes about this Site:
Robert Roessle Comprehensive Cancer Center - Charite Campus Buch Website:
http://cccc.charite.de/en/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.